FRIDAY, Jan. 24, 2025 (HealthDay News) — Hesitancy over the COVID-19 vaccine is leading some parents to skip important vaccinations for their children. Young children of parents who declined the COVID vaccine are about 25% less likely to get the standard measles/mumps/rubella (MMR) vaccine, researchers reported in a new studyContinue Reading
FRIDAY, Jan. 24, 2025 (HealthDay News) — People using weed for medical purposes are as likely – or more – to become addicted to cannabis as recreational tokers, a new study says. Folks using medical marijuana were more likely to have cannabis use disorder than those who get high recreationally,Continue Reading
Agency cites contamination at Massachusetts plant where company makes ingredients used to produce various medicinesContinue Reading
-690x550.jpg)
THURSDAY, Jan. 23, 2025 (HealthDay News) — Preventing or treating infections could be a key means of warding off dementia, a new evidence review says. Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, researchers reported in a study published Jan. 21 inContinue Reading
Drug is the first and only approved monotherapy for refractory major depressive disorderContinue Reading
WEDNESDAY, Jan. 22, 2025 (HealthDay News) — With a sweep of the pen, President Donald Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid. Trump’s order, signed shortly after his inauguration on Monday, targets policies his administrations calls “deeplyContinue Reading
TUESDAY, Jan. 21, 2025 (HealthDay News) — The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu. This funding, announced Friday by Moderna, builds on the $176 million it received from HHS lastContinue Reading
TUESDAY, Jan. 21, 2025 (HealthDay News) — Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as substance abuse, psychosis, infections and even dementia. But these drugs also come with risks that shouldn’t be overlooked, researchers warn in a study publishedContinue Reading
Approval based on results from phase 3 VIVID-1 trial, in which end points of clinical remission and endoscopic response were met at one yearContinue Reading
WEDNESDAY, Jan. 8, 2025 (HealthDay News) — Public health officials must prepare to counter ongoing anti-vaccine sentiment in coming years, argues a leading pediatrician-scientist. “Antivaccine activism became a major lethal force in America” during the COVID-19 pandemic, resulting in an estimated 200,000 deaths among the unvaccinated, according to an articleContinue Reading